The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
Condition(s):SchizophreniaLast Updated:October 18, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:October 18, 2016Unknown status
Condition(s):HealthyLast Updated:April 20, 2012Completed
Condition(s):HealthyLast Updated:April 20, 2012Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:November 19, 2014Completed
Condition(s):Bipolar DisorderLast Updated:March 3, 2021Terminated
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:July 29, 2011Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Bipolar DisorderLast Updated:November 29, 2012Completed
Condition(s):Medication Adherence; Bipolar DisorderLast Updated:December 30, 2014Completed
Condition(s):Schizoaffective Disorder; SchizophreniaLast Updated:February 21, 2021Completed
Condition(s):Bipolar DisorderLast Updated:October 22, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.